- Home
- RDVT vs BVS Comparison
RDVT vs BVS Comparison
Compare RDVT & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDVT
- BVS
- Stock Information
- Founded
- RDVT 2017
- BVS 2011
- Country
- RDVT United States
- BVS United States
- Employees
- RDVT N/A
- BVS N/A
- Industry
- RDVT Computer Software: Prepackaged Software
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RDVT Technology
- BVS Health Care
- Exchange
- RDVT Nasdaq
- BVS Nasdaq
- Market Cap
- RDVT 503.6M
- BVS 496.7M
- IPO Year
- RDVT N/A
- BVS 2021
- Fundamental
- Price
- RDVT $45.47
- BVS $6.78
- Analyst Decision
- RDVT
- BVS Strong Buy
- Analyst Count
- RDVT 0
- BVS 4
- Target Price
- RDVT N/A
- BVS $15.00
- AVG Volume (30 Days)
- RDVT 103.1K
- BVS 444.9K
- Earning Date
- RDVT 05-07-2025
- BVS 05-06-2025
- Dividend Yield
- RDVT 0.64%
- BVS N/A
- EPS Growth
- RDVT N/A
- BVS N/A
- EPS
- RDVT 0.61
- BVS N/A
- Revenue
- RDVT $79,681,000.00
- BVS $567,699,000.00
- Revenue This Year
- RDVT $15.93
- BVS N/A
- Revenue Next Year
- RDVT $13.85
- BVS $6.09
- P/E Ratio
- RDVT $76.14
- BVS N/A
- Revenue Growth
- RDVT 26.30
- BVS 8.60
- 52 Week Low
- RDVT $19.41
- BVS $4.51
- 52 Week High
- RDVT $46.85
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- RDVT 78.35
- BVS 36.21
- Support Level
- RDVT $38.00
- BVS $6.02
- Resistance Level
- RDVT $40.10
- BVS $7.07
- Average True Range (ATR)
- RDVT 1.63
- BVS 0.38
- MACD
- RDVT 0.93
- BVS -0.01
- Stochastic Oscillator
- RDVT 97.79
- BVS 38.27
About RDVT Red Violet Inc.
Red Violet Inc is a software and services company. It specializes in big data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses and assets.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.